2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (9804):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-D0184S3
    2'-Deoxycytidine-13C9,15N3
    		99.00%
    2'-Deoxycytidine-13C9,15N3 (Deoxycytidine-13C9,15N3; Cytosine deoxyriboside-13C9,15N3; Deoxyribose cytidine-13C9,15N3) is 13C and 15N-labeled 2'-Deoxycytidine (HY-D0184). 2'-Deoxycytidine, a deoxyribonucleoside, could inhibit biological effects of Bromodeoxyuridine (Brdu).
    2'-Deoxycytidine-<sup>13</sup>C<sub>9</sub>,<sup>15</sup>N<sub>3</sub>
  • HY-133588S
    4-Formylaminoantipyrine-d3
    		99.71%
    4-Formylaminoantipyrine-d3 is the deuterium labeled 4-Formylaminoantipyrine (HY-133588). 4-Formylaminoantipyrine is an excreted metabolite of Aminophenazone. Aminophenazone is a pyrazolone with analgesic, anti-inflammatory, and antipyretic effects in vivo.
    4-Formylaminoantipyrine-d<sub>3</sub>
  • HY-17504S
    Rosuvastatin-d6 calcium
    		98.54%
    Rosuvastatin-d6 (calcium) is deuterium labeled Rosuvastatin.
    Rosuvastatin-d<sub>6</sub> calcium
  • HY-W654078
    Bisphenol AF-13C12
    		99.24%
    Bisphenol AF-13C12 is an isotopic label of Bisphenol AF. Bisphenol AF is used in polycarbonate plastic and epoxy resin manufacturing. Bisphenol AF can significantly increase intracellular ROS levels.
    Bisphenol AF-<sup>13</sup>C<sub>12</sub>
  • HY-W012510S
    2,4-Dichlorobenzoic acid-d3
    2,4-Dichlorobenzoic acid-d3 is the deuterium labeled 2,4-Dichlorobenzoic acid.
    2,4-Dichlorobenzoic acid-d<sub>3</sub>
  • HY-B1244S
    Dimetridazole-d3
    		99.87%
    Dimetridazole-d3 is a deuterium labeled Dimetridazole (HY-B1244). Dimetridazole is a nitroimidazole antibiotic. Dimetridazole inhibits protein synthesis in cultures of Campylobacter jejuni. Dimetridazole is genotoxic. Dimetridazole can be used in the research of protozoal and bacterial infections.
    Dimetridazole-d<sub>3</sub>
  • HY-17538AS
    ZLN005-d4 hydrochloride
    ZLN005-d4 hydrochloride is the deuterium labeled ZLN005.
    ZLN005-d<sub>4</sub> hydrochloride
  • HY-146930S
    16:1 SM (d18:1/16:1)-d9
    		≥99.0%
    16:1 SM (d18:1/16:1)-d9 is deuterium labeled 16:1 SM (d18:1/16:1).
    16:1 SM (d18:1/16:1)-d<sub>9</sub>
  • HY-10569S
    Ponesimod-d4
    Ponesimod-d4 (ACT-128800-d4) is the deuterium labeled Ponesimod (HY-10569). Ponesimod (ACT-128800) is a potent, selective and orally active agonist of S1P1, with an IC50 of 6 nM in a radioligand binding assay. Ponesimod activates S1P1-mediated signal transduction with high potency (EC50=5.7 nM). Ponesimod can protect against lymphocyte-mediated tissue inflammation.
    Ponesimod-d<sub>4</sub>
  • HY-108321S
    Zofenopril-d5
    		99.92%
    Zofenopril-d5 is deuterium labeled Zofenopril. Zofenopril is an angiotensin-converting enzyme (ACE) inhibitor with an IC50 of 81 μM.
    Zofenopril-d<sub>5</sub>
  • HY-W016034S
    Acetaminophen glucuronide-d3 sodium salt
    Acetaminophen glucuronide-d3 sodium salt is the deuterium labeled Acetaminophen glucuronide sodium salt.
    Acetaminophen glucuronide-d<sub>3</sub> sodium salt
  • HY-B0414AS
    Fleroxacin-d3 hydrochloride
    		98.78%
    Fleroxacin-d3 (hydrochloride) is the deuterium labeled Fleroxacin (hydrochloride).
    Fleroxacin-d<sub>3</sub> hydrochloride
  • HY-B1267S1
    Sulfaguanidine-13C6
    		≥99.0%
    Sulfaguanidine-13C6 is the 13C6 labeled Sulfaguanidine. Sulfaguanidine is an orally active antimicrobial agent/antibiotic of sulfonamide class. Sulfaguanidine can be used for the research of enteric infections such as bacillary dysentery.
    Sulfaguanidine-<sup>13</sup>C<sub>6</sub>
  • HY-113066S2
    Guanosine 5'-diphosphate-d13 dilithium
    Guanosine 5'-diphosphate-d13 (GDP-d13) dilithium is deuterium labeled Guanosine 5'-diphosphate (HY-113066). Guanosine 5'-diphosphate (GDP) is a nucleoside diphosphate that activates adenosine 5'-triphosphate-sensitive K+ channel. Guanosine 5'-diphosphate is a potential iron mobilizer, which prevents the hepcidin-ferroportin interaction and modulates the interleukin-6 (IL-6)/stat-3 pathway. Guanosine 5'-diphosphate can be used in the research of inflammation, such as anemia of inflammation (AI).
    Guanosine 5'-diphosphate-d<sup>13</sup> dilithium
  • HY-N0384S3
    Homovanillic acid-13C6,18O
    		99.2%
    Homovanillic acid-13C6,18O is the 13C-labeled Homovanillic acid. Homovanillic acid is a dopamine metabolite found to be associated with aromatic L-amino acid decarboxylase deficiency, celiac disease, growth hormone deficiency, and sepiapterin reductase deficiency.
    Homovanillic acid-<sup>13</sup>C<sub>6</sub>,<sup>18</sup>O
  • HY-W654210
    Glycopyrrolate-d3 bromide
    		≥99.0%
    Glycopyrrolate-d3 (bromide) is deuterium labeled Glycopyrrolate. Glycopyrrolate (Glycopyrronium bromide), a quaternary ammonium derivative, is a muscarinic receptor antagonist. Glycopyrrolate has bronchoprotective effect and produces a beneficial effect on blood pressure. Glycopyrrolate can be used for the research of bronchial diseases.
    Glycopyrrolate-d<sub>3</sub> bromide
  • HY-B0625S
    Ciclesonide-d7
    		99.99%
    Ciclesonide-d7 is the deuterium labeled Ciclesonide. Ciclesonide (RPR251526) is a glucocorticoid with an potent anti-inflammatory activity. Ciclesonide can be used for asthma research.
    Ciclesonide-d<sub>7</sub>
  • HY-Y0069S1
    N-Acetylglycine-d2
    N-Acetylglycine-d2 (Aceturic acid-d2) is the deuterated labeled N-Acetylglycine (HY-Y0069). N-Acetylglycine (Aceturic acid) is a minor constituent of numerous foods. N-Acetylglycine is a flavor enhancer which elicits Monosodium glutamate (MSG)-like sensory experiencesN-Acetylglycine.
    N-Acetylglycine-d<sub>2</sub>
  • HY-19883S
    Lusutrombopag-d13
    		98.64%
    Lusutrombopag-d13 is deuterium labeled Lusutrombopag. Lusutrombopag is an orally bioavailable thrombopoietin (TPO) receptor agonist, used for treatment of chronic liver disease.
    Lusutrombopag-d<sub>13</sub>
  • HY-W653842
    Taurocholic acid-d8 sodium
    		98.83%
    Taurocholic acid-d8 (sodium) is deuterium labeled Taurocholic acid (sodium). Taurocholic acid sodium (Sodium taurocholate) has marked bioactive effects such as an inhibitory potential against hepatic artery ligation induced biliary damage by upregulation of VEGF-A expression. Taurocholic acid sodium has immunoregulation effect.
    Taurocholic acid-d<sub>8</sub> sodium